Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Our results indicated NF1 mutations served as a good prognostic factor in EGFR mutant/TP53 wild-type lung cancer patients in this single-center study. TP53 mutation was obviously enriched in NF1 mutant patients and had shorter OS.